Product Image

Dual-Release Melatonin 3 mg

Swanson Ultra
4.7
★ ★ ★ ★ ★
(996 ratings)
Melatonin 3 mg
Product Image
Score85
A simple 3 mg dual-release tablet offers useful onset and maintenance coverage at strong value. The release split is not disclosed.
How scoring works
Quantity:60 Tablet(s) • (60 servings)
Goals:
Sleep Support

Score 85

A simple 3 mg dual-release tablet offers useful onset and maintenance coverage at strong value. The release split is not disclosed.
How scoring works
$6.99($0.11 per serving)
iHerb
$ 6.99
Report prices

Analysis

The 3 mg total amount sits in a moderate range for adults who need more than a very low dose. Dual release is a meaningful formulation feature for people who struggle both to fall asleep and remain asleep.

Melatonin is the only active ingredient, which keeps interaction screening straightforward. The immediate and delayed portions are not separately quantified in the supplied data.

A one-tablet serving and low routine cost support practical use. People who only have sleep-onset difficulty may not need the prolonged exposure.

Who is it for
  • Adults with both sleep-onset and maintenance difficulty
  • People seeking dual-release melatonin
  • Users comfortable with a 3 mg total amount
Best for
  • Overnight sleep support
  • Combined onset and maintenance needs
  • Low-cost sustained use

Pros

  • Dual-release delivery
  • Clear 3 mg total
  • Single active ingredient
  • Low serving cost

Cons

  • Release proportions are not stated
  • Cannot easily tailor immediate versus delayed amount
  • May cause morning grogginess
  • Tablet flexibility is limited

Warnings

  • Prolonged melatonin exposure may increase morning drowsiness
  • Do not combine with alcohol or other sedating products without guidance

Nutrient quality

94 Highest impact

Dual-release delivery supports both sleep onset and overnight maintenance. The melatonin amount fits a practical sleep-support range.

Ingredient transparency

78 High impact

The melatonin and any listed supporting nutrients have specific amounts. The provided facts omit the complete inactive-ingredient and flavoring list.

Customer satisfaction

72 High impact

The supplied aggregate rating is very strong. No specific review comments are provided to assess whether negative complaints repeat.

Value for money

95 Highest impact

The dose and delivery provide strong practical quality for the formula cost. The very low recurring cost provides excellent serving value.

Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA Strength of SupportC+ CoverageA+ Formula Quality
Melatonin · 3 mg

Melatonin directly supports circadian timing and sleep onset. Dual-release delivery combines an initial signal with extended overnight exposure.

The focused formula does not address relaxation or mineral pathways, but its circadian purpose is clear. The amount sits within a commonly used range, though sensitive users may prefer less to reduce next-day grogginess.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
3 mg
Adults 18–50
Report overview
Melatonin · 3 mg OverallScore73
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA- Value

The 3 mg amount sits within the range most aligned with natural circadian signaling. Dual-release technology adds overnight support, though the hard tablet may slow the initial phase. The low serving cost and overnight-release feature provide good practical value.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S · Neuroscience and biobehavioral reviews · 2022
    Meta-analysis1,998 participants34 studies pooledSleep Support forMelatonin
  3. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.
    Li T; Jiang S; Han M; Yang Z; Lv J; Deng C; Reiter RJ; Yang Y · Frontiers in neuroendocrinology · 2019
    Meta-analysis205 participants7 studies pooledSleep Support forMelatonin
  4. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  5. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  6. Effects of melatonin on postoperative sleep quality: a systematic review, meta-analysis, and trial sequential analysis.
    Tsukinaga A; Mihara T; Takeshima T; Tomita M; Goto T · Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023
    Meta-analysis516 participants8 studies pooledSleep Support forMelatonin
  7. Unintended consequences: college students' melatonin usage, sleep disturbance, and depressive symptoms.
    Peltz JS; Rogge R · Sleep and biological rhythms · 2025
    Cohort study331 participantsSleep Support forMelatonin
  8. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  9. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  10. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin